GlassScriptPhysician profile
Alisha Flannery
NPI 1598191819
$7,427.61
in general payments reported to CMS, 2019-2025
27 companies · $1,667 in 2025
The $1,667 reported for 2025 was more than what 91% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $881 · 2022: $683 · 2023: $534 · 2024: $3,663 · 2025: $1,667.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,773 · Travel and Lodging: $1,090.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,773.35 |
| Travel and Lodging | $1,090.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,470.64 | 2021-2025 | Watchman Flx |
| Janssen Pharmaceuticals, INC | $608.70 | 2021-2024 | Xarelto |
| Amgen INC. | $474.96 | 2021-2025 | Repatha, Repatha |
| Kestra Medical Technology Services, INC. | $440.24 | 2023-2025 | Assure Wcd |
| Abbott Laboratories | $364.01 | 2021-2025 | Triclip, Cardiomems, Mitraclip |
| Astrazeneca Pharmaceuticals LP | $360.64 | 2021-2025 | Farxiga, Wainua |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $339.56 | 2021-2025 | Lifevest |
| Impulse Dynamics (USA) INC. | $313.01 | 2024-2025 | Optimizer |
| Novartis Pharmaceuticals Corporation | $266.87 | 2021-2025 | |
| Medtronic, INC. | $226.55 | 2021-2025 | Linq II, Pulseselect, Aurora Ev-Icd Mri Surescan |
| E.R. Squibb & Sons, L.L.C. | $226.34 | 2022-2024 | Camzyos, Eliquis |
| Novo Nordisk INC | $168.56 | 2024-2025 | Wegovy, Ozempic, Rybelsus |
| Edwards Lifesciences Corporation | $142.84 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $138.06 | 2022-2025 | |
| Abiomed | $123.48 | 2024-2025 | Impella |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kiniksa Pharmaceuticals International, Plc | $116.80 | 2024 | Arcalyst |
| Esperion Therapeutics, INC. | $103.10 | 2021 | |
| Irhythm Technologies, INC. | $81.06 | 2023-2024 | Zio Xt Patch, Zio Monitor |
| Heartflow, INC. | $73.86 | 2023-2025 | Ffrct |
| Bridgebio Pharma, INC. | $71.97 | 2025 | Attruby |
| Merck Sharp & Dohme LLC | $71.74 | 2023-2024 | Verquvo |
| Cvrx, INC. | $63.91 | 2025 | Barostim Neo System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $58.34 | 2024-2025 | Jardiance |
| Pfizer INC. | $57.32 | 2023-2024 | |
| Alnylam Pharmaceuticals INC. | $28.54 | 2024 | |
| Siemens Medical Solutions USA, INC. | $19.61 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $16.90 | 2023 | Uptravi, Opsumit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alisha Flannery listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.